A University of Washington (UW) spinout focused on developing vaccines for COVID-19 and other respiratory illnesses says the $100 million in Series B financing it just completed will enable it to ...

Advantages of Utilizing a Light-Scattering Toolbox in Vaccine Development Virus-like particles (VLPs) are biomolecular nanoparticles formed by controlled self-assembly of viral structural proteins.

With the continuing COVID-19 pandemic, several researchers have brought out candidate vaccines, some of which have undergone human testing. However, it is unclear whether they are genuinely protective ...

SEATTLE--(BUSINESS WIRE)--Icosavax, Inc. today announced the launch of the company with a $51 million Series A financing, led by Qiming Venture Partners USA and joined by Adams Street Partners, Sanofi ...

In a study published in the latest issue of the Scientific Reports, a team of researchers constructed virus-like particles (VLPs) composed of severe acute respiratory syndrome coronavirus 2 ...

A more affordable, lower-risk polio vaccine is on the horizon, research has found. A more affordable, lower-risk polio vaccine is on the horizon, research led by the University of Leeds has found.

Upon administration, VLPs are uptake by APC, like dendritic cells. VLPs can be presented by MHC-I or MHC-II, which are recognized by CD8+ and CD4+ T cells, respectively. For cellular response, CD8+ ...

Nanomedicine. 2014;9(12):1857-1868. A major area of interest in the field of vaccine development for lung-associated pathogens like influenza is new vaccine strategies that will provide broad serotype ...

Upon administration, VLPs are uptake by APC, like dendritic cells. VLPs can be presented by MHC-I or MHC-II, which are recognized by CD8+ and CD4+ T cells, respectively. For cellular response, CD8+ ...

The lung is a major entry point for many of the most detrimental pathogens to human health. The onslaught of pathogens encountered by the lung is counteracted by protective immune responses that are ...